Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta‐analysis of randomized clinical trials

BACKGROUND: Immune checkpoint inhibitors (ICIs) showed antitumor activity for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results from different studies were controversial. METHODS: Online databases were searched for randomized clinical trials (RCTs) evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Shoutao, Zhang, Shurong, Zhao, Jingyang, Li, Xinyu, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652313/
https://www.ncbi.nlm.nih.gov/pubmed/37814950
http://dx.doi.org/10.1002/cam4.6564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652313/
https://www.ncbi.nlm.nih.gov/pubmed/37814950
http://dx.doi.org/10.1002/cam4.6564

Ejemplares similares